期刊文献+

组织蛋白酶S与糖尿病患者颈动脉内膜中膜厚度的关系 被引量:1

The Relationship Study Between Cathepsin S and Atherosclerosis in Diabetes
下载PDF
导出
摘要 目的探讨组织蛋白酶S在糖尿病动脉粥样硬化发生发展过程中的作用。方法 83位糖尿病患者按颈动脉内膜中膜厚度(IMT)分为3组。糖尿病伴中度动脉粥样硬化组20例,IMT≥1.0 mm,或有一个以上动脉粥样硬化斑块;糖尿病伴轻度动脉粥样硬化组23例,IMT 0.8-0.99 mm,糖尿病不伴动脉粥样硬化组40例,IMT〈0.8 mm;正常对照组21例。所有对象均测定组织蛋白酶S、颈动脉内膜中膜厚度、糖化血红蛋白(HbA1 c)、血糖、血脂。结果糖尿病伴中度动脉粥样硬化组和糖尿病伴轻度动脉粥样硬化组组织蛋白酶S值与正常对照组比较显著升高(P〈0.001),且组织蛋白酶S值随着颈动脉内膜中膜厚度的增加而升高,成正比关系;糖尿病不伴动脉粥样硬化组组织蛋白酶S值与正常对照组比较差异无显著性(P〉0.05),与糖尿病伴中度动脉粥样硬化组和糖尿病伴轻度动脉粥样硬化组比较差异有显著性(P〈0.001);糖尿病3组组间糖化血红蛋白、血糖、血脂差异均无显著性(P〉0.05),与正常对照组比较差异有显著性(P〈0.01)。结论组织蛋白酶S在糖尿病动脉粥样硬化患者血清中显著升高,且随着颈动脉内膜中膜厚度值的增加值越高,血清组织蛋白酶S测定可以作为诊断糖尿病动脉粥样的监测指标。 Aim To explore the relationship between cathepsin S in the process occurrence and development of atherosclerosis in diabetes. Methods 83 diabetic patients detected by carotid artery intima-media thickness(IMT) were divided into three groups: 20 diabetic cases with moderate atherosclerosis group,IMT≥1.0 mm,or with more than one atherosclerotic plaque;23 diabetic cases with mild atherosclerosis group,IMT 0.8~0.99 mm;40 diabetic cases without atherosclerosis group,IMT 0.8 mm;21 cases of normal control group.The levels of HbA1c,CatS,blood glucose,blood lipids,IMT results were measured in all subjects. Results Compared with the control group CatS value was significantly higher in diabetic group with moderate atherosclerosis and mild atherosclerosis(P0.001),and increased positively with IMT;CatS value had no significant change in diabetic group without atherosclerosis and the normal control group(P0.05);compared with the first group and the second group CatS value was significantly different(P0.001);in the diabetic group of glucose,blood lipids,HbA1c was not significantly different(P0.05),and in normal control group was significantly different(P0.01). Conclusion CatS level in diabetic patients was significantly increased,and related to IMT values.CatS determination of serum can be used as diagnostic indicators for monitoring diabetes,atherosclerosis.
作者 谭庆玲
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第7期574-576,共3页 Chinese Journal of Arteriosclerosis
关键词 糖尿病动脉粥样硬化 颈动脉中膜厚度 组织蛋白酶S Atherosclerosis Intima-Media Thickness Cathepsin S
  • 相关文献

参考文献8

  • 1Izbela Berdowska. Cysteine proteases as disease markers [ J ]. Clinica Chimica Acta, 2004, 342 (19) : 41-69.
  • 2Sukhova GK, Zhang Y, Pan JH, et al. Dificiency of cathepsin S reduces atherosclerosis in LDL receptor-de fincientmece [ J ]. J Clin Invest, 2003, 121 (6) : 897-906.
  • 3Shah PK, Falk E, Bakimon J J, et al. Human monocytederived macrophages induce collagen breakdown in fibrous caps of atherescleroticplaques: potential role of matrix - degra ding metalloproteinases and implications for plaque rupture [J]. Circulation, 1995, 92 (8) : 1 565-569.
  • 4Eriksson P, Deguchi H, Samnegard A. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery, disease [ J ]. Arteioscler THromb Vasc Biol, 2004, 24 (7) : 551-557.
  • 5LIBBY P. Inflammation in atherosclerosis [ J ]. Nature, 2002 , 420 (17) : 868-874.
  • 6Layne MD, Ye Q , Le L. IFN regulatory factor-1 regulates IFN-Y-dependent cathepsin S expression [ J ]. J Immunol, 2002, 168 (14) : 4 488- 494.
  • 7冯波,王华,赵秀丽.应用基因芯片探讨阿托伐他汀对糖尿病大鼠动脉组织基因谱表达的影响[J].中华糖尿病杂志(1006-6187),2005,13(6):465-466. 被引量:5
  • 8徐雷,冯波,王华,王军臣,符雪莲.高脂饮食对GK大鼠动脉组织蛋白酶S表达的影响[J].基础医学与临床,2007,27(2):200-201. 被引量:2

二级参考文献7

  • 1冯波,王华,赵秀丽.应用基因芯片探讨阿托伐他汀对糖尿病大鼠动脉组织基因谱表达的影响[J].中华糖尿病杂志(1006-6187),2005,13(6):465-466. 被引量:5
  • 2Sukhova GK, Zhang Y, Pan JH, et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest, 2003, 111: 897-906.
  • 3Henriksen PA, Hitt M, Xing Z, et al. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappaB-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J Immunol,2004, 172: 4535-4544.
  • 4Reixach N, Deechongkit S, Jiang X, et al. Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci USA, 2004, 101: 2817-2822.
  • 5Navarro A, Del Valle E, Astudillo A, et al. Immunohistochemicai study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp Neurol, 2003, 184: 697-704.
  • 6Sukhova GK,Zhang Y,Pan JH,et al.Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice[J].J Clin Invest,2003,111(6):897 -906.
  • 7杨国庆,陆菊明.同型半胱氨酸与糖尿病及其并发症[J].国外医学(内科学分册),2000,27(4):159-161. 被引量:25

共引文献5

同被引文献14

  • 1Samokhin AO, Lythgo PA, Gauthier JY, et al. Pharmacological Inhibition of Cathepsin S Decreases Atherosclerotic Lesions in Apoe-/-Mice[J]. J Cardiovasc Pharmacol, 2010,56 ( 1 ) : 12-28.
  • 2Berdowska I. Cysteine proteases as disease markers [J]. Clinic Chim Aeta,2004,342 (1/2): 41-69.
  • 3Mirzaii-Dizgah I, Riahi E. Serum and saliva levels of cathepsin L inpatients with acute coronary syndrome[J]. J Contemp Dent Pract, 2011,58(6) :972-975.
  • 4Kim H, Mazumdar B,Bose SK, et al. Hepatitis C virus-medi atedinhibition of cathepsin S increases invariant-chain expres siononhepatocyte surface [J]. J Virol, 2012,86 (18): 9 919- 9 928.
  • 5Stern I, Marc J, Kranjec I, et al. Increased plasma levels of CATSmRNA but not CATB mRNA in patients with coronary atherosclerosis[J]. Clin Biochem, 2010,43(18):1 427-1 430.
  • 6Samokhin AO, Lythgo PA, Gauthier JY, et al. Pharmacolo gical inhibition of cathepsin S decreases atherosclerotic lesions in Apoe-/-mice[J]. J Cardiovasc Pharmacol, 2010,56 ( 1 ) : 98- 105.
  • 7Mattock KL, Gough PJ, Humphries J, et al. Legumain and ca thepsin-L expression in human unstable carotid plaque[J]. Atherosclerosis, 2010,208 (1): 83-89.
  • 8DE Nooijer R,Bot I,von der Thusen JH,et al. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis [J]. Arterioscler Thromb Vasc Bilo,2009,29(2):188-194.
  • 9Li Z, Yasuda Y, Li W, et al. Regulation of collagenase activi ties of humancathepsins by glycosaminoglycans [J]. J Biol Chem, 2004,279 (7): 470-479.
  • 10Qin Y, Cao X, Zhang Y, et al. Deficiency of cathepsin S at tenuatesangiotensin II-induced abdominal aortic aneurysm formation inapolipoprotein E-deficient mice [J]. Cardiovasc Res,2012,96 (3) :401-410.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部